Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts
Volf, E.M.; Levine, D.E.; Michelon, M.A.; Au, S.-C.; Patvardhan, E.; Dumont, N.; Loo, D.S.; Kuvin, J.; Gottlieb, A.B.
Journal of Drugs in Dermatology Jdd 10(8): 900-901
2011
ISSN/ISBN: 1545-9616 PMID: 21818512 Document Number: 11071
Adult patients with psoriasis have an increased prevalence of the metabolic syndrome (MetS) and cardiovascular disease (CVD) risk factors due to elevations of Tumor Necrosis Factor and other inflammatory cytokines.1,2 Recently, higher rates of hyperlipidemia, obesity, hypertension, and diabetes mellitus were seen in patients with juvenile psoriasis.3 Here, we report the interim results of an ongoing study of MetS and CVD risk factors in pediatric psoriasis patients.
Document emailed within 1 workday
Related Documents
Han, C.; Lofland, J.H.; Zhao, N.; Schenkel, B. 2011: Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis Journal of Drugs in Dermatology: Jdd 10(8): 843-850Arnaiz, P.; Pino, F.; Marín, A.; Barja, S.; Aglony, M.; Cassis, B.; Navarrete, C.; Acevedo, Mónica. 2010: Association between a cardiovascular risk score and early markers of atherosclerotic disease in Chilean children Revista Medica de Chile 138(10): 1226-1231
Brown, N.; Sasidharan, C.K.; Fisher, D. 2010: Early growth and markers of cardiovascular risk in Keralan children in the Integrated Child Development Scheme Public Health Nutrition 13(7): 1042-1048
Korpela, M.; Mustonen, J.; Heikkinen, A.; Helin, H.; Pasternack, A. 1995: Isolated microscopic hematuria in patients with rheumatoid arthritis compared with age and sex matched controls. A population based study Journal of Rheumatology 22(3): 427-431
Fiuza, M.; Cortez-Dias, N.; Martins, S.; Belo, A.; Dias, A.D.C.; Neves, A.S.; Frazão, A.é; Pereira, A.ón.A.P.; Do Vale, A.ón.F.M.; Dias Simas, A.M.; Estrela, C.; Amorim, E.A.; Almeida, F.E.M.; Amaral, G.M.B.; Silva, I.M.S.; Sousa, J.M.M.; Morgado, J.M.O.; Santos, J.é C.O.; Senra, J.é F.M.; Amaral, L.G.M.; Aleixo, L.G.; Soares, L.M.S.; Cafede, M.C.F.A.; Colleo, M.O.M.C.; Senra, M.C.M.; Ramiro, M.J.R.C.C.; Borges, M.M.S.A.P.; Amaral, P.N.P.; Andrade, R.M.L.; Costa, R.P.D.R.C.; Conde, A.I.; Rodrigues, A.; Santana, A.; Morais, A.S.; Cardoso, A.A.M.V.; Barros, A.; Perez, A.; Matias, A.; Carina, A.; Cardoso, A.M.C.S.E.; Dinis, A.R.F.; Santana, A.; Baltazar, A.; Vieira, A.ón.J.é C.; Farias, A.M.; Martins, A.V.; Magalhães, A.M.B.; Graça,; 2008: Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 27(12): 1495-1529
Kircik, L.; Lebwohl, M.G.; Del Rosso, J.Q.; Bagel, J.; Stein Gold, L.; Weiss, J.S. 2013: Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis Journal of Drugs in Dermatology: Jdd 12(12): 1404-1410
Szychta, M.; Wiernicka, A.; Dądalski, M.; Landowski, P.; Klincewicz, B.; Karolewska-Bochenek, K.; Czaja-Bulsa, G.ży.; Jarocka-Cyrta, E.; Korczowski, B.; Sladek, M.; Kierkus, J. 2016: Assessment of induction therapy with infliximab in children with moderate to severe ulcerative colitis: a multi-center study Developmental Period Medicine 20(3): 205-211
Siritaratiwat, W.; Inthachom, R.; Warnset, S. 2012: The usage of a hand-made chair at home for children with moderate to severe cerebral palsy: preliminary study Journal of the Medical Association of Thailand 95(2): 198-204
Ghannem, H.; Ben Abdelaziz, A.; Limam, K.; Gaha, R.; Ghedira, A.; Harrabi, I.; Essoussi, A.S. 2005: Tracking of cardiovascular risk factors among school children: a four-year population surveillance in Susa, Tunisia La Tunisie Medicale 83(7): 404-408
Milos, C.; Casanueva, V.; Campos, R.; Cid, X.; Silva, V.; Rodríguez, W.; Rodríguez, M.S. 1990: Risk factors of cardiovascular disease in a Chilean school population: I: Blood lipids in 552 children and adolescents 6-15 years of age Revista Chilena de Pediatria 61(2): 67-73
Panigalli, S.; Coccarielli, D.; Germi, L.; Trevisan, G.P.; Veller-Fornasa, C. 2009: Non-randomized pilot study on the evaluation of the quality of life and psychosocial stress before and after systemic therapy in patients affected by moderate to severe psoriasis Journal of Biological Regulators and Homeostatic Agents 23(2): 111-117
Pop, E.; Popa, I.; Bolcaş, D.; Spineanu, R.; Curteanu, G.; Stoici, L.; Pop, V.; Chirică, S.; Isac, G.; Negoescu, E.; Rittli, L.; Nistor, A.; Pop, M.; Puriş, Z.; Crişan, O.; Stan, M.; Balaj, V.; Liviu, M.; Pop, V. 1983: Cholesterolemia and total lipidemia in children aged 5-14. Average normal limits and prevalence of hyperlipidemias (prospective studies in an infantile population of 27,500 children in the framework of the Oradea Study of Risk Factors in Coronary Disease Revista de Pediatrie Obstetrica Si Ginecologie. Pediatria 32(1): 39-50
Vanaman Wilson, M.J.; Jones, I.T.; Bolton, J.; Larsen, L.; Wu, D.C.; Goldman, M.P. 2017: A Randomized, Investigator-Blinded Comparison of two Topical Regimens in Fitzpatrick Skin Types III-Vi with Moderate to Severe Facial Hyperpigmentation Journal of Drugs in Dermatology: Jdd 16(11): 1127-1132
Lui, H.; Gulliver, W.; Tan, J.; Hong, C-Ho.; Hull, P.; Shear, N.H.; Paradiso-Hardy, F.; Bissonette, R. 2012: A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response Journal of Drugs in Dermatology: Jdd 11(8): 929-937
Bird, S.T.; Hartzema, A.G.; Brophy, J.M.; Etminan, M.; Delaney, J.A.C. 2013: Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis Cmaj: Canadian Medical Association Journal 185(2): E115-E120
Molero-Conejo, E.; Morales, L.Marina.; Fernández, V.; Raleigh, X.; Gómez, M.Esther.; Semprún-Fereira, M.; Campos, G.; Ryder, E. 2003: Lean adolescents with increased risk for metabolic syndrome Archivos Latinoamericanos de Nutricion 53(1): 39-46
Elliott, H.L. 1998: Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point? Journal of Cardiovascular Pharmacology 32(Suppl 3): S74-S77
Charbonnel, B. 2005: Metabolic syndrome and cardiovascular risk La Revue du Praticien 55(16): 1765-1771
Pan, C.-Y.; Cheng, Y. 2004: Metabolic syndrome: a high-cardiovascular risk Zhonghua Nei Ke Za Zhi 43(11): 801-802
Vuletić, S.; Kern, J.; Ivanković, D.; Polasek, O.; Brborović, O. 2007: Metabolic syndrome in the Croatian population--the multiple cardiovascular risks Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 61(3): 239-243